Mark D. TrailSmith
Impact in
-
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Biotechnology top 10%
- Cancer Research and Treatments
Papers in
- Co-authors
- Robert S. Mittler (1 shared paper)Kerry Klussman (1 shared paper)Michael K. Hoffmann (1 shared paper)Peter V.N. Bodine (1 shared paper)Barry S. Komm (1 shared paper)Marc Charette (1 shared paper)R. Bruce Rutherford (1 shared paper)MARIA EMANUEL RYAN (1 shared paper)
- Journals
- Journal of Medicinal Chemistry (2 papers)Archives of Oral Biology (1 paper)The Journal of Experimental Medicine (1 paper)Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (1 paper)Journal of Bone and Mineral Research (1 paper)
- Partner nations
- United StatesGermanyFrance
In The Last Decade
Mark D. TrailSmith
8 papers receiving 458 citations
Peers
Comparison fields: 5 of 61
- Immunology 157
- Biotechnology 60
- Urology 35
- Oncology 116
- Oral Surgery 17
Countries citing papers authored by Mark D. TrailSmith
This map shows the geographic impact of Mark D. TrailSmith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark D. TrailSmith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark D. TrailSmith more than expected).
Fields of papers citing papers by Mark D. TrailSmith
This network shows the impact of papers produced by Mark D. TrailSmith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark D. TrailSmith. The network helps show where Mark D. TrailSmith may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark D. TrailSmith, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 160 | |
| 2 | 1996 | 83 | |
| 3 | 2001 | 60 | |
| 4 | 1992 | 60 | |
| 5 | Effect of linker variation on the stability, potency, and efficacy of carcinoma-reactive BR64-doxorubicin immunoconjugates. | 1997 | 47 |
| 6 | Enhanced antitumor activity of paclitaxel in combination with the anticarcinoma immunoconjugate BR96-doxorubicin. | 1999 | 37 |
| 7 | 2002 | 26 | |
| 8 | 2000 | 6 |
About Mark D. TrailSmith
Mark D. TrailSmith is a scholar working on Oncology, Genetics, Endocrinology, Diabetes and Metabolism, Hepatology and Orthopedics and Sports Medicine, having authored 8 papers that have together received 479 indexed citations. Recurring topics across this work include Virus-based gene therapy research (2 papers), Peptidase Inhibition and Analysis (2 papers), HER2/EGFR in Cancer Research (1 paper), Phosphodiesterase function and regulation (1 paper), Cancer Research and Treatments (1 paper), Bone health and osteoporosis research (1 paper), Lymphoma Diagnosis and Treatment (1 paper) and Alkaline Phosphatase Research Studies (1 paper). The work is most often cited by research in Immunology (157 citations), Biotechnology (60 citations), Urology (35 citations), Oncology (116 citations) and Oral Surgery (17 citations). Mark D. TrailSmith has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Robert S. Mittler, Kerry Klussman, Michael K. Hoffmann, Peter V.N. Bodine, Barry S. Komm, Marc Charette, R. Bruce Rutherford, MARIA EMANUEL RYAN, Ingegerd Hellström and David Willner. Their work appears in journals such as Journal of Medicinal Chemistry, Archives of Oral Biology, The Journal of Experimental Medicine, Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics and Journal of Bone and Mineral Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.